<- Go Home
Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Market Cap
DKK 98.1B
Volume
302.9K
Cash and Equivalents
DKK 817.0M
EBITDA
DKK 11.6B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
DKK 19.1B
Profit Margin
67.23%
52 Week High
DKK 646.60
52 Week Low
DKK 369.70
Dividend
5.28%
Price / Book Value
7.34
Price / Earnings
35.53
Price / Tangible Book Value
-7.02
Enterprise Value
DKK 121.1B
Enterprise Value / EBITDA
10.16
Operating Income
DKK 7.7B
Return on Equity
18.53%
Return on Assets
10.12
Cash and Short Term Investments
DKK 817.0M
Debt
DKK 23.8B
Equity
DKK 13.4B
Revenue
DKK 28.4B
Unlevered FCF
DKK 8.1B
Sector
Health Care Equipment and Supplies
Category
N/A